Shandong Sinobioway Biomedicine Co., Ltd.

¥4.08As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002581Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (16.63%)
Div yield —
ROE (11.47%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.27
PE TTM —
TSR TTM (47.76%)
Mkt cap ¥2.692B
ROIC (12.06%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.22
28.01%
(44.50%)
Sell 5|7|2|4|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.05
0.05
0.06
0.06
19.85%
21.03%
18.03%
21.61%
Revenue¥M
149.6
157.9
161.9
162.0
1.87%
7.16%
9.81%
6.80%
Peers (US$403.5M)
Cap (US$)
PE
402.8M
19.69x
Capital
TTM
5Y
10Y
Leveragex
2.543
0.256
0.268
EBIT/Intx
1.456
2.730
2.140
Own earn%
(103.90)
(94.23)
(93.43)
Sh yield%
47.88
46.13
46.01
Owners
Insiders/Inst%
6.09
38.70
Short interest%
4.42
SBC / revenue%
1.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
11–17
$1 testx
—
Incr. ROIC%
5